Bangkok Genomics Innovation Public Company Limited

Bangkok Genomics Innovation Public Company Limitedverified

BKGI.BK

Price:

$1.34

Market Cap:

$804.00M

Bangkok Genomics Innovation Public Company Limited provides clinical and genomics services in Thailand. The company offers non-invasive prenatal testing which includes screening for fetal chromosomal abnormalities under the NIFTY brand; and genetic disease carrier screening testing services, such as screening before embryo implantation, carriers of genetic disease, and detection of gene abnormalities associated with thalassemia anemia under the VISTA brand. It also provides real time-PCR test for COVID-19, antigen testing of the COVID-19, SARS-CoV-2 serology testing, SARS-CoV-2 neutralizing antibody testing, and real time-PCR for monkeypox virus testing, as well as HPV DNA test; colon cancer...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2024-03-18

Stock Exchange

SET

Ticker

BKGI.BK

The PE Ratio as of December 2025 (TTM) for Bangkok Genomics Innovation Public Company Limited (BKGI.BK) is 26.80

According to Bangkok Genomics Innovation Public Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 26.80. This represents a change of -22.05% compared to the average of 34.38 of the last 4 quarters.

Bangkok Genomics Innovation Public Company Limited (BKGI.BK) Historical PE Ratio (quarterly & annually)

How has BKGI.BK PE Ratio performed in the past?

The mean historical PE Ratio of Bangkok Genomics Innovation Public Company Limited over the last ten years is 12.50. The current 26.80 PE Ratio has changed 21.33% with respect to the historical average. Over the past ten years (40 quarters), BKGI.BK's PE Ratio was at its highest in in the June 2023 quarter at 62.11. The PE Ratio was at its lowest in in the September 2021 quarter at 1.25.

Quarterly (TTM)
Annual

Average

12.50

Median

16.81

Minimum

-18.96

Maximum

30.43

Bangkok Genomics Innovation Public Company Limited (BKGI.BK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bangkok Genomics Innovation Public Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 427.52%

Maximum Annual PE Ratio = 30.43

Minimum Annual Increase = -188.66%

Minimum Annual PE Ratio = -18.96

Quarterly (TTM)
Annual
YearPE RatioChange
202424.87-18.26%
202330.43133.69%
202213.02427.52%
20212.47-86.94%
202018.9012.40%
201916.81-188.66%

Bangkok Genomics Innovation Public Company Limited (BKGI.BK) Average PE Ratio

How has BKGI.BK PE Ratio performed in the past?

The current PE Ratio of Bangkok Genomics Innovation Public Company Limited (BKGI.BK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

22.77

5-year avg

17.94

10-year avg

12.50

Bangkok Genomics Innovation Public Company Limited (BKGI.BK) PE Ratio vs. Peers

How is BKGI.BK’s PE Ratio compared to its peers?

Bangkok Genomics Innovation Public Company Limited’s PE Ratio is greater than Dental Corporation Public Company Limited (16.93), greater than Intermedical Care and Lab Hospital Public Company Limited (-4.82), greater than Kt Medical Service Public Company Limited (19.63), greater than E for L Aim Public Company Limited (8.05), greater than Winnergy Medical Public Company Limited (12.76), less than Techno Medical Public Company Limited (62.65), greater than Healthlead Public Company Limited (20.01), greater than LDC Dental Public Company Limited (-38.27), greater than Aikchol Hospital Public Company Limited (10.66), greater than Business Alignment Public Company Limited (10.36),

Build a custom stock screener for Bangkok Genomics Innovation Public Company Limited (BKGI.BK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bangkok Genomics Innovation Public Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bangkok Genomics Innovation Public Company Limited (BKGI.BK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bangkok Genomics Innovation Public Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bangkok Genomics Innovation Public Company Limited's PE Ratio?

How is the PE Ratio calculated for Bangkok Genomics Innovation Public Company Limited (BKGI.BK)?

What is the highest PE Ratio for Bangkok Genomics Innovation Public Company Limited (BKGI.BK)?

What is the 3-year average PE Ratio for Bangkok Genomics Innovation Public Company Limited (BKGI.BK)?

What is the 5-year average PE Ratio for Bangkok Genomics Innovation Public Company Limited (BKGI.BK)?

How does the current PE Ratio for Bangkok Genomics Innovation Public Company Limited (BKGI.BK) compare to its historical average?